Enhanced Activity of Osteoblast Differentiation Factor (PEBP2αA2/CBFa1) in Affected Sutural Osteoblasts from Patients with Nonsyndromic Craniosynostosis

Abstract

Objective:

Nonsyndromic craniosynostosis is characterized by premature closure of one or more cranial sutures in infants. The purpose of this investigation was to evaluate cellular and molecular events that lead to pathogenesis of nonsyndromic craniosynostosis.

Design:

This study utilized discarded samples of normal and affected cranial sutures from 12 patients (7 boys, 5 girls) with nonsyndromic craniosynostosis.

Results:

Histological evaluation of affected sutures revealed complete osseous obliteration instead of a zone of connective tissue and osteogenic cells as seen in normal sutures. Although proliferation of normal and affected osteoblasts did not vary substantially, elevated osteocalcin production and increased in vitro bone nodule formation indicated that the differentiation and the bone-forming potential of affected osteoblasts was significantly higher than that of normal cells. We therefore investigated the levels and activity of Cbfa1, a transcription factor that plays an integral role in osteoblast differentiation. Northern blot analysis of messenger RNA from both normal and affected sutural osteoblasts revealed a twofold increase in the expression of Cbfa1 in affected cells. This increase in the level of Cbfa1 transcript correlated with an increase in its transcriptional activity on the osteocalcin gene promoter, as assessed using gene transfer methods.

Conclusion:

Our results indicated that osteoblasts from synostosed sutures exhibit an increased potential for differentiation and bone formation. The increased level and activity of Cbfa1 could play a vital role in the aberrant function of these affected osteoblasts and may explain their altered behavior compared to the normal cells.

Keywords

bone Cbfa1 craniosynostosis nonsyndromic osteoblasts

Get full access to this article

View all access options for this article.

References

Bodine

P.V.

Vernon

S.K.

Komm

B.S.

Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone.

Endocrinology. 1996; 137: 4592–4603.

Bradley

J.P.

Han

V.K.

Roth

D.A.

Levine

J.P.

McCarthy

J.G.

Longaker

M.T.

Increased IGF-I and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion.

Plast Reconstr Surg. 1999; 104: 129–138.

Bradley

J.P.

Levine

J.P.

McCarthy

J.G.

Longaker

M.T.

Studies in cranial suture biology: regional dura mater determines the in vitro cranial suture fusion.

Plastic Reconstr Surg. 1997; 100: 1091–1099.

Carson

F.L.

Pigments, minerals, cytoplasmic granules. In: Carson

F.L.

, ed. Histotechnology—A Self-Instructional Text. Chicago: ASCP Press; 1986: 224–226.

Clemens

T.L.

Tang

Maeda

Kesterson

R.A.

DeMayo

Pike

J.W.

Gundberg

C.M.

Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.

J Bone Miner Res. 1997; 12: 1570–1576.

Cohen

M.M.

Jr.

Sutural biology and the correlates of craniosynostosis.

Am J Med Genet. 1993; 47: 581–616.

Cohen

M.M.

Transforming growth factor βs and fibroblast growth factors and their receptors: role in sutural biology and craniosynostosis.

J Bone Miner Res. 1997; 12: 322–331.

Ducy

Karsenty

Genetic control of cell differentiation in the skeleton.

Curr Opin Cell Biol. 1998; 10: 614–619.

Ducy

Starbuck

Priemel

Shen

Pinero

Geoffroy

Amling

Karsenty

A Cbfa1-dependent genetic pathway controls bone formation beyond embryo development.

Genes Dev. 1999; 13: 1025–1036.

10.

Ducy

Zang

Geoffroy

Ridall

Karsenty

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Cell. 1997; 89: 747–754.

11.

Elias

J.M.

Principles and Techniques of Diagnostic Histopathology. Parkridge, NJ: Noyes Publications; 1982: 248–250.

12.

Geoffroy

Corral

D.A.

Zhou

Lee

Karsenty

Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function.

Mamm Genome. 1998; 9: 54–57.

13.

Gundberg

C.M.

Clough

M.E.

Carpenter

T.O.

Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse.

Endocrinology. 1992; 130: 1909–1915.

14.

Harada

Tagashira

Fujiwara

Ogawa

Katsumata

Yamaguchi

Komori

Nakatsuka

Cbfa1 isoforms exert functional differences in osteoblast differentiation.

J Biol Chem. 1999; 274: 6972–6978.

15.

Jin

C.H.

Kerner

S.A.

Hong

M.H.

Pike

J.W.

Transcriptional activation and dimerization functions in the human vitamin D receptor.

Mol Endocinol. 1996; 10: 945–957.

16.

Karsenty

The genetic transformation of bone biology.

Genes Dev. 1999; 13: 3037–3051.

17.

Kerner

S.A.

Scott

R.A.

Pike

J.W.

Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D.

Proc Natl Acad Sci USA. 1989; 86: 4455–4459.

18.

Kingsley

The TGF-β superfamily: new members, new receptors, and new genetic tests for function in different in organisms.

Genes Dev. 1994; 8: 133–146.

19.

Kokich

V.G.

The biology of sutures. In: Cohen

M.M.

, ed. Craniosynostosis: Diagnosis, Evaluation and Management. New York: Raven Press; 1986: 81–103.

20.

Komori

Yagi

Nomura

Yamaguchi

Sasaki

Deguchi

Shimuzu

Bronson

R.T.

Gao

Y.H.

Kitamura

Yoshiki

Kishimoto

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrests of osteoblasts.

Cell. 1997; 89: 755–764.

21.

Lajeunie

Le Merrer

Bonaiti-Pellie

Marchac

Renier

Genetic study of nonsyndromic coronal craniosynostosis.

Am J Med Genet. 1995; 55: 500–504.

22.

Lian

J.B.

Stein

G.S.

Stein

J.L.

van Wijnen

A.J.

Transcriptional control of osteoblast differentiation.

Biochem Soc Trans. 1998; 26: 14–21.

23.

Lin

K.Y.

Nolen

A.A.

Gampper

T.J.

Jane

J.A.

Opperman

L.A.

Ogle

R.C.

Elevated levels of transforming growth factor beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly.

Cleft Palate Craniofac J. 1997; 34: 331–337.

24.

Marie

P.J.

Human osteoblastic cells: a potential tool to assess the etiology of pathologic bone formation.

J Bone Miner Res. 1994; 9: 1847–1850.

25.

Marie

P.J.

Lomri

Sabbagh

Basel

Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces.

In Vitro Cell Biol Dev. 1989; 25: 373–380.

26.

Massague

The transforming growth factor-β family.

Annu Rev Cell Dev Biol. 1990; 6: 597–641.

27.

McLarren

K.E.

Garbavec

Thirunavukkarasu

Karsenty

Stifani

The mammalian basic helix-loop-helix protein HES-1 binds to and modulates transactivating function of the runt-related factor Cbfa1.

J Biol Chem. 2000; 275: 530–538.

28.

Meikle

M.C.

Bord

Hembry

R.M.

Reynolds

J.J.

The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-1 and-2 by human osteoblasts from normal and arthritic bone.

Bone. 1995; 17: 255–260.

29.

Menkes

J.H.

Malformations of the central nervous system. In: Taeusch

H.W.

Ballard

R.A.

Avery

M.E.

, eds. Schaffer and Avery's Diseases of the Newborn. 6th ed. Philadelphia: WB Saunders, 1991.

30.

Miyamoto

Kesterson

R.A.

Yamamoto

Taketani

Nishiwaki

Tatsumi

Inoue

Morita

Takeda

Pike

J.W.

Structural organization of the human vitamin D receptor chromosomal gene and its promoter.

Mol Endocrinol. 1997; 11: 1165–1179.

31.

Most

Levine

J.P.

Chang

McCarthy

J.G.

Schendel

S.A.

Longaker

M.T.

Studies in cranial suture biology: up-regulation of transforming growth factor-beta 1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture in rat.

Plast Reconstr Surg. 1998; 101: 1431–1440.

32.

Mullink

Henzen-Logmans

S.C.

Tadema

T.M.

Mol

J.J.

Meijer

C.J.L.M.

Influence of fixation and decalcification on the immunohistochemical staining of cell specific markers in paraffin-embedded human bone biopsies.

J Histochem Cytochem. 1985; 33: 1103–1109.

33.

Opperman

L.A.

Chhabra

Cho

R.W.

Ogle

R.C.

Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro.

J Craniofac Genet Dev Biol. 1999; 19: 164–73.

34.

Opperman

L.A.

Nolen

A.A.

Ogle

R.C.

TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro.

J Bone Miner Res. 1997; 12: 301–310.

35.

Otto

Thornell

A.P.

Crompton

Denzel

Gilmour

K.C.

Rosewell

I.R.

Stamp

G.W.H.

Beddington

R.S.P.

Mundlos

Olsen

Selby

P.B.

Owen

M.J.

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Cell. 1997; 89: 765–771.

36.

Ozono

Sone

Pike

J.W.

The genomic mechanism of action of 1,25-dihydroxyvitamon D3.

J Bone Miner Res. 1991; 6: 1021–1027.

37.

Pollack

C.D.

Renier

Hott

Marie

P.J.

Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis).

J Bone Miner Res. 1996; 11: 401–407.

38.

Renier

Ghouzzi

V.E.

Bonaventure

Merrer

M.L.

Lajeunie

Fibroblast growth factor receptor 3 mutation in nonsyndromic coronal synostosis: clinical spectrum, prevalence, and surgical outcome.

J Neurosurg. 2000; 92: 631–636.

39.

Roth

D.A.

Longaker

M.T.

McCarthy

J.G.

Rosen

D.M.

McMullen

H.F.

Levine

J.P.

Sung

Gold

L.I.

Studies in cranial suture biology: Part 1. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion.

J Bone Miner Res. 1997; 12: 311–321.

40.

Shevde

N.K.

Bendixen

A.C.

Maruyama

Billmire

D.A.

Evaluation of molecular and cellular signals in nonsyndromic craniosynostosis (abstract). Presented at the 56th Annual Meeting of the American Cleft Palate Association; April 1999; Scottsdale, Arizona.

41.

Stein

Montecino

van Wijnen

Stein

Lian

J.B.

Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer.

Cancer Res. 2000; 60: 2067–2076.

42.

Stevens

Lowe

Bancroft

Bone. In: Bancroft

J.D.

Stevens

, eds. Theory and Practice of Histological Techniques. New York: Churchill and Livingstone Inc.; 1972: 327.

43.

Tintut

Parhami

Karsenty

Demer

L.L.

Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pattern in osteoblastic cells.

J Biol Chem. 1999; 274: 28875–28879.

44.

Wilkie

A.O.M.

Craniosynostosis: genes and mechanisms.

Hum Mol Genet. 1997; 6: 1647–1656.

45.

Winograd

J.M.

M.J.

Vander Kolk

C.A.

Osteoblastic and osteoclastic activation in coronal sutures undergoing fusion ex vivo.

Plast Reconstr Surg. 1997; 100: 1103–1112.

46.

Xiao

Jiang

Thomas

Benson

M.D.

Guan

Karsenty

Francheschi

R.T.

MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor Cbfa1.

J Biol Chem. 2000; 275: 4453–4459.